Tailored meals may boost recovery in ICU patients
NCT ID NCT07149246
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether personalized nutrition from a dietitian helps critically ill patients get more energy and protein during and after their ICU stay. Researchers will compare usual care with a tailored plan for 300 adults over 6 months. The goal is to see if this approach improves nutrition intake and recovery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dietitian-tailored nutrition intervention
- What this could lead to
- If it works, this could show that personalized nutrition helps critically ill patients recover better by meeting their energy and protein needs.
- What could go wrong
- This is a single-center study with 300 participants, so results may not apply to all ICU patients. It focuses on nutrition intake, not direct health outcomes like survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patients in intensive care who gives an informed consent and meet all of the following will be eligible: 1. Admitted to the intensive care unit for \>48 hours. 2. At least 18 years of age 3. Have one or more organ system failure (respiratory,cardiovascular or renal) related to their acute illness defined as: a. PaO2/FiO2≤300 mm Hg) b. Currently on one or more continuous inotrope/vasopressor infusion which were started at least 4 hours ago at a minimum dose of: i. Norepinephrine≥0.1 mcg/kg/min ii. Epinephrine≥0.1 mcg/kg/min iii. Any dose of vasopressin iv. Milrinone\>0.1 mcg/kg/min) c. Renal dysfunction defined as: i. Serum creatinine 2.0-2.9 times baseline or ii. Urine output 0.5 mL/kg/hour for ≥12 hours or iii. Currently receiving renal replacement therapy) d. Currently has an intracranial pressure monitor or ventricular drain in situ 4. Permanent living address in Norway Exclusion Criteria: Patients will be excluded if: 1. Death is imminent in the next 96 hours or there is a current treatment limitation in place or the patient is unlikely to survive to 180 days due to underlying/chronic illness 2. Dialysis dependent chronic renal failure 3. Suspected or known pregnancy 4. Wheelchair user 5. Cognitive impairment in which intervention is considered not appropriate 6. Eating disorders -
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Critical illness are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University Hospital of North Norway
RECRUITINGTromsø, 9037, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Why do some ICU patients bleed in the gut? researchers map the risk
- Hidden pressure: how continuous kidney dialysis may affect the abdomen in ICU patients
- Do antibiotics reach the battlefield? muscle probe tests drug delivery in sick kids
- Do ICU family meetings for the very old vary across europe?
- COVID-19's hidden toll: muscle wasting in the ICU
- Can protein and pedaling save ICU Patients' muscles?